Skip to main content
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.540
-0.100 (-2.75%)
At close: Mar 5, 2026, 4:00 PM EST
3.430
-0.110 (-3.11%)
Pre-market: Mar 6, 2026, 9:02 AM EST

Recursion Pharmaceuticals Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021
Operating
74.26M 43.42M 64.51M 59.82M 58.49M 64.60M 48.62M 45.23M
Operating Growth
26.96% -32.80% 32.69% 32.24% 33.30% 37.66% -2.52% -2.76%
Grant
425.00K 274.00K 95.00K 278.00K 618.00K - 1.01M 1.00M 699.11K - -
Grant Growth
-31.23% -72.98% -90.52% -60.23% 36.39% - 1,707.26% 1,037.25% 473.04% - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.